U.S. health officials are reevaluating a $590 million contract that was awarded to Moderna for the development of its bird ...

Nutanix jumped 14% after posting fiscal second-quarter earnings and revenue that beat analysts' forecasts. Nvidia reported sharply higher quarterly sales and profit, but a narrower profit margin.

Goldman Sachs trims its staff, cutting what it deems to be the underperformers. This year, VPs stand to be big targets, BI ...

FILE PHOTO: David Dubner of Goldman Sachs attends a gathering of top global M&A advisors, including Wall Street's most ...

Improving economic conditions and a more favorable regulatory environment give Goldman Sachs catalysts to benefit from in the ...

Goldman Sachs initiated coverage of Sionna Therapeutics (SION) with an Early-Stage Biotech designation. Lead assets SION-719 and SION-451 are ...

ASX 200 futures are up 17pts (+0.21%) as of 8:30 am AEDT. In a nutshell: ASX set to bounce after two-session losing streak ...

Usually, only one or two sector weightings vary by more than 3 percentage points from the index levels, or—as is the case currently—none fall outside that range (according to Goldman Sachs ...

ASX 200 futures are down 69pts (-0.84%) as of 8:30 am AEDT. In a nutshell: Nasdaq logs worst day in a month S&P 500 turns ...

"How can we help?" is the question we ask ourselves every day. I have been proudly leading the Contact 6 segment since 2016. Our goal is simple: to make a positive difference in our community.

Sharon Goldman is an AI reporter at Fortune.Previously, she covered AI for VentureBeat. Sharon has written about digital and enterprise tech for over a decade, for publications and organizations ...